Jamison Private Wealth Management’s GSK GSK Stock Holding History

Jamison Private Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$963K	Sell	18,369 -162	-0.9%	-$8.57K	0.1%	124
2026 Q1	$1.02M	Buy	18,531 +919	+5%	+$49.8K	0.12%	117
2025 Q4	$864K	Sell	17,612 -293	-2%	-$13.7K	0.1%	123
2025 Q3	$773K	Buy	17,905 +645	+4%	+$25.2K	0.1%	128
2025 Q2	$663K	Sell	17,260 -227	-1%	-$8.67K	0.1%	129
2025 Q1	$677K	Buy	17,487 +449	+3%	+$16.4K	0.1%	120
2024 Q4	$576K	Sell	17,038 -811	-5%	-$29.2K	0.09%	136
2024 Q3	$730K	Buy	17,849 +784	+5%	+$32.1K	0.11%	116
2024 Q2	$657K	Buy	17,065 +1,292	+8%	+$54.3K	0.11%	113
2024 Q1	$676K	Buy	15,773 +142	+0.9%	+$5.86K	0.11%	119
2023 Q4	$579K	Sell	15,631 -408	-3%	-$14.6K	0.11%	125
2023 Q3	$581K	Buy	+16,039	New	+$569K	0.12%	113

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Jamison Private Wealth Management's GSK Position: Q2 2026 in Review

Jamison Private Wealth Management reduced its GSK (GSK) stake by 0.87% in Q2 2026, selling an estimated $8.57K and leaving 18,369 shares worth $963K. The position accounts for 0.1% of the portfolio, ranked #124.

Jamison Private Wealth Management first reported a position in GSK in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.02M in Q1 2026. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Jamison Private Wealth Management held 18,369 shares of GSK worth $963K as of Q2 2026.
Jamison Private Wealth Management sold 162 GSK shares in Q2 2026, an estimated $8.57K.
GSK made up 0.1% of Jamison Private Wealth Management's portfolio in Q2 2026, its #124 holding.
Jamison Private Wealth Management first reported a position in GSK in Q3 2023 and has held it in 12 quarters since.
Jamison Private Wealth Management's GSK position peaked at $1.02M in Q1 2026.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Jamison Private Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.